Market Snapshot

BSE Sensex: 81332.72 1.62%
BSE 500: 36795.89 1.65%
BSE 200: 11475.13 1.74%
BSE 100: 26248.18 1.76%
BSE MidCap: 47706.67 2.12%
BSE SmallCap: 54294.35 1.00%
BSE BANKEX: 58638.77 0.86%
BSE IT: 41836.85 2.15%
Nifty 50: 24834.85 1.76%
Nifty 500: 23292.05 1.64%
Nifty 200: 14039.2 1.73%
Nifty 100: 25841.9 1.71%
Nifty Midcap 100: 57768.1 1.81%
Nifty Small 100: 18854 0.97%
Nifty IT: 40977.35 2.30%
Nifty PSU Bank: 7270.65 1.66%

News:

BHEL receives LOI for Rs 10,00...
Gujarat Themis Q1 PAT falls ov...
Power Grid Q1 PAT rises 3% YoY...
IndusInd Bank PAT rises to Rs ...
Cipla spurts as Q1 PAT rises 1...

Samrat Pharmachem Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

26 Jul 2024 | 03:59 PM

342.10

-5.20 (-1.50%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-16.05%

Return (1Y)

Underperformed BSE Sensex by 37.97%
More Volatile

2.79%

Standard Deviation (1Y)

Higher than BSE Sensex by 1.98%
Inconsistent Performer

2/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

459

320

News & Announcements

Samrat Pharmachem to declare Quarterly Result
27 days ago

Samrat Pharmachem to declare Quarterly Result

29 - Jun - 2024 12:00 AM | 27 days ago

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 13 August 2024.
Powered by Capital Market - Live News
Samrat Pharmachem AGM scheduled
28 days ago

Samrat Pharmachem AGM scheduled

28 - Jun - 2024 12:00 AM | 28 days ago

Samrat Pharmachem announced that the 32th Annual General Meeting (AGM) of the company will be held on 26 September 2024.
Powered by Capital Market - Live News
Board of Samrat Pharmachem recommends final dividend
57 days ago

Board of Samrat Pharmachem recommends final dividend

31 - May - 2024 12:00 AM | 57 days ago

Samrat Pharmachem announced that the Board of Directors of the Company at its meeting held on 30 May 2024, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News

Samrat Pharmachem reports standalone net profit of Rs 1.40 crore in the March 2024 quarter

57 days ago

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

Samrat Pharmachem Ltd is trading very close to its 52 Week Low

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60